Nachrichten zur QuidelOrtho Corp. Aktie

Is QDEL Worth Buying as China Risks Clash With Resilient Core Growth?

QuidelOrthos resilient core growth and $50 million cost plan offer support, but China weakness, cash use and heavy debt keep…

QDEL Rallies 31.7% in Three Months: Can the Stock Keep Climbing Higher?

QuidelOrthos 31.7% three-month rally meets resilient core growth and cost savings, but China weakness, lower guidance and high debt cloud…

Why QuidelOrtho (QDEL) Stock Is Nosediving

Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 21.3% in the afternoon session after the company slashed its full-year revenue…

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory…

4 Medical Products Stocks Poised to Win Despite Industry Headwinds

Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.…

Pivotal-Point Nachverfolgung QuidelOrtho (QDEL): Strategischer Verkauf der Point-of-Care-Sparte löst massiven Kurssprung aus

QuidelOrtho ist ein weltweit führender Anbieter im Bereich der In-vitro-Diagnostik und entwickelt hochentwickelte Testlösungen für Labore und Arztpraxen. Am 29.…

QuidelOrtho plans to sell testing unit for $1.5B: FT

…

QuidelOrtho looks to sell testing unit as PE circles healthcare companies

Diagnostic company’s shares are down 90% since its rapid antigen tests were the first to be approved for Covid-19…

QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue?

QuidelOrtho (QDEL) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

QuidelOrthos Respiratory Exposure Remains a Key Near-Term Risk

QDELs Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market…

QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y

QuidelOrtho posts a wider Q1 loss as revenues fell 10.5% year over year, with weakness in respiratory testing pressuring margins…

QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of -110.81% and +0.28%, respectively, for the quarter ended March 2026. Do the…

QuidelOrtho Looks Mispriced If 2026s FCF Turnaround Materializes

…

QuidelOrtho stock plunges on weak revenue guidance

QuidelOrtho stock plunges on weak revenue guidance…

QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires

QuidelOrtho Corporations stock has been falling for multiple years, but after a board member purchased shares, could the stock soon…

QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down

QDEL beats Q4 estimates as Labs and global growth lift sales, but shrinking margins and respiratory weakness weigh on profits.…

QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of +7.80% and +3.62%, respectively, for the quarter ended December 2025. Do the…

QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand

QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines.…

QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?

QuidelOrtho (QDEL) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

QuidelOrtho explodiert: 40?% Plus nach Zahlenvorlage

QuidelOrtho Corporation ist ein weltweit führendes Unternehmen im Bereich der In-vitro-Diagnostik mit Hauptsitz in den USA. Entstanden aus der Fusion…

QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of 27.59% and 0.30%, respectively, for the quarter ended March 2025. Do the…

QuidelOrtho (QDEL) Earnings Expected to Grow: Should You Buy?

QuidelOrtho (QDEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains?

QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might…

QuidelOrtho Unveils Results Manager System to Streamline Testing

QDEL introduces the Results Manager System, a powerful tool designed to streamline diagnostic data management, enhance efficiency, and improve patient…

QuidelOrtho: Growth Struggles And Negative GAAP Earnings Continue To Disinterest Investors

…

$30+ Bn Primary Care POC Diagnostics Market Opportunities and Strategies to 2033: F. Hoffmann-La Roche Leads with 10.51% Share, Followed by Siemens Healthineers and QuidelOrtho

Dublin, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The "Primary Care POC Diagnostics Market Opportunities and Strategies to 2033"…

Why QuidelOrtho Stock Bounced More Than 4% Higher Today

Healthcare in vitro diagnostics company QuidelOrtho (NASDAQ: QDEL) attracted the right kind of attention from investors after posting its latest…

QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of 14.55% and 0.79%, respectively, for the quarter ended December 2024. Do the…

QuidelOrtho expands board with healthcare veterans By Investing.com

QuidelOrtho expands board with healthcare veterans…

QuidelOrtho: Highly Levered With Questionable Growth

…

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QuidelOrtho (QDEL) Q2 Earnings Beat Estimates, U.S. Sales Down

QuidelOrthos (QDEL) second-quarter results reflect growth in revenues. However, gross profit continues to decline.…

Carlyle group entities sell over $4.8 million in QuidelOrtho stock By Investing.com

Carlyle group entities sell over $4.8 million in QuidelOrtho stock…

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QDEL INVESTOR ALERT: Kirby McInerney LLP Alerts QuidelOrtho Corporation Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

QuidelOrtho (QDEL) Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman

HAGENS BERMAN Encourages QDEL Investors Who Suffered Substantial Losses to Contact Firm HAGENS BERMAN Encourages QDEL Investors Who Suffered Substantial…

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm,…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL

NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm

NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QuidelOrtho gains as activist Jana shows new share stake By Investing.com

QuidelOrtho gains as activist Jana shows new share stake…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and Sharecare and Encourages Investors to Contact the Firm

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall

QuidelOrthos (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and Sharecare and Encourages Investors to Contact the Firm

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)

LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm

NEW YORK, April 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…